FDA Slaps Boxed Warning on Osteoporosis Drug
MedPage Today) — The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday. After a review…
Read More
Recent Comments